Skip to main content
Oxford University Hospitals NHS Foundation Trust

Alert Coronavirus / COVID-19

If you have a new continuous cough, a high temperature, or a loss or change to your sense of taste or smell, do not come to our hospitals. Follow the national advice on coronavirus (COVID-19).

Please find information on our services and visiting restrictions in our COVID-19 section.

Patients and visitors must wear a face covering in our hospitals.

This site is best viewed with a modern browser. You appear to be using an old version of Internet Explorer.

A study to assess the new candidate Zika vaccine in healthy adults

Trial categories: Vaccines

Sponsoring organisation: University of Oxford

A phase I study to determine the safety and immunogenicity of the candidate Zika Virus (ZIKV) vaccine ChAdOx1 Zika in healthy adult volunteers given as a standalone vaccine or co-administered with the Chikungunya Virus (CHIKV) candidate vaccine ChAdOx1 Chik

Zika Vaccine Study (ZIKA001)

A phase I study to determine the safety and immunogenicity of the candidate Zika Virus (ZIKV) vaccine ChAdOx1 Zika in healthy adult volunteers.

If you are aged 18-50 and are in good health, you may be eligible to participate.

The trial will involve 10 visits over a period of 12 months and participants will receive up to £460 on completion of the study.

For more information and to apply: www.jenner.ac.uk/zika001

Email: vaccinetrials@ndm.ox.ac.uk